Stockscreener 앱 받기
0.675
3.77%
0.0245
전일 마감가:
$0.6505
열려 있는:
$0.665
하루 거래량:
111.44K
Relative Volume:
0.25
시가총액:
$21.33M
수익:
$1.22M
순이익/손실:
$-22.43M
주가수익비율:
-0.5837
EPS:
-1.1564
순현금흐름:
$-18.78M
1주 성능:
-2.24%
1개월 성능:
-12.36%
6개월 성능:
+8.29%
1년 성능:
-55.00%
1일 변동 폭
$0.6601
$0.68
1주일 범위
$0.6003
$0.6899
52주 변동 폭
$0.475
$1.80
Longeveron Inc Stock (LGVN) Company Profile
명칭
Longeveron Inc
전화
305-302-7158
주소
1951 NW 7TH AVENUE, MIAMI
Compare LGVN vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
0.675 | 21.33M | 1.22M | -22.43M | -18.78M | -1.1564 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-06 | 개시 | ROTH MKM | Buy |
Longeveron Inc 주식(LGVN)의 최신 뉴스
LGVN Stock Slips After Hours As FDA Flags Concerns On Rare Heart Defect Trial Design - Stocktwits
Longeveron Inc. Issues Special Equity Awards to Executive Chairman – SEC 8-K Filing Highlights Company Growth 7 - Minichart
Form 4 Longeveron LLC For: 8 July By Investing.com - Investing.com Nigeria
Longeveron (LGVN) CSO Hare granted 600k RSUs and 400k options - Stock Titan
Longeveron grants special equity awards to Executive Chairman - TipRanks
Longeveron (LGVN) awards 600,000 RSUs and 400,000 options to Executive Chairman - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Longeveron names Marie Washburn as CFO - MSN
Form 4 Longeveron LLC For: 6 July By Investing.com - Investing.com Nigeria
Longeveron (NASDAQ: LGVN) CTO has 15,808 shares withheld for taxes - Stock Titan
Longeveron (LGVN) CFO has shares withheld to cover RSU tax obligations - Stock Titan
Longeveron (LGVN) counsel reports RSU tax-withholding share disposition - Stock Titan
Longeveron strengthens financial leadership with new CFO appointment - TipRanks
Longeveron Appoints Marie Washburn as Chief Financial Officer - citybiz
New Longeveron (NASDAQ: LGVN) CFO and reverse stock split approval - Stock Titan
Longeveron taps Marie Washburn as CFO ahead of July trial readout - Stock Titan
Longeveron (LGVN) Slips as Bearish Momentum Pressures Support at $0.66Mutual Fund Flow - dars.gov.et
Price to sales forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Enterprise value to revenue forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Enterprise value to EBITDA forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Price to book forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Price to earnings forward of Longeveron Inc. – NASDAQ:LGVN - TradingView
Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update - The National Law Review
Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update - The National Law Review
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study - Stocktwits
Longeveron Inc. Class A Actuals & Estimates (NASDAQ:LGVN) - TradingView
LGVN Forecast — Price Target — Prediction for 2027 - TradingView
LGVN News | LONGEVERON INC-A (NASDAQ:LGVN) - ChartMill
Longeveron Inc (LGVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Longeveron’s Alzheimer’s trial data accepted for poster presentation - Investing.com UK
Longeveron’s Alzheimer’s trial data accepted for poster presentation By Investing.com - Investing.com South Africa
Longeveron to Present Additional Phase 2a Laromestrocel Data in Mild Alzheimer’s Disease at AAIC 2026 - Quiver Quantitative
Longeveron gets AAIC poster slot for Alzheimer’s stem cell data - Stock Titan
Longeveron Inc (LGVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Longeveron Inc (LGVN) Institutional Confidence - TradingKey
Longeveron Inc (LGVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Longeveron Inc (LGVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Longeveron Inc (LGVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Longeveron Inc (LGVN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Longeveron Inc (LGVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Longeveron Inc (LGVN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Longeveron receives SME status from European regulator By Investing.com - Investing.com Nigeria
Longeveron receives SME status from European regulator - Investing.com UK
Longeveron Granted SME Status by European Medicines Agency - Moomoo
Longeveron Inc. Awarded SME Status by European Medicines Agency, Enhancing Drug Development Opportunities - Quiver Quantitative
Biotech Longeveron wins EMA SME status, where SME drugs saw 89% OKs - Stock Titan
Number of shareholders of Longeveron Inc. – BOATS:LGVN - TradingView
LGVN Q1 2026 Earnings: Deeper Losses Weigh on Shares as Clinical Progress ContinuesGross Profit Margin - newsline.com
Longeveron Announces CFO Transition to Internal Successor - TipRanks
LongeveronOn June 1, Lisa Locklear To Step Down As CFO Effective July 10, 2026SEC Filing - TradingView
Longeveron (NASDAQ: LGVN) CFO Lisa Locklear to step down, controller eyed as successor - Stock Titan
Longeveron Inc (LGVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):